Skip to content

PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03617380
Enrollment
0
Registered
2018-08-06
Start date
2018-10-01
Completion date
2020-02-10
Last updated
2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease, Chronic

Brief summary

Many hospitals and medical groups have developed transitions of care (TOC) programs or procedures in an attempt to reduce hospital readmission and reutilization rates of patients discharged from the hospital. As healthcare's most accessible practitioners, Community Pharmacists have a unique opportunity to assist with reducing unnecessary hospital re-utilization (re-admissions and emergency department visits) after hospital discharge. The purpose of this study is to conduct and evaluate the implementation of a Community Pharmacy-based Transitions of Care (TOC) Program for high-risk post-discharge patients of PIH Health Hospital-Whittier (PIH). The primary objective will be to compare the proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge between patients randomly assigned to the PHARMD-TOC group vs. the historic rate at PIH. Secondary analyses will examine differences between groups and describe implementation details of the PHARMD-TOC model of patient care.

Interventions

OTHERUsual Care

patients participating Usual Care discharge services

OTHERPharmD TOC

patients participating in a community pharmacy-based Transitions of Care Program (PHARMD-TOC)

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \- Admission LACE Score: in moderate range (5 to 9) And * Taking high risk medication(s): anticoagulants, insulin, oral antiplatelet agents, oral hypoglycemic agents, opioid analgesics, digoxin Or Taking at least 5 medications AND have one of following: CHF, COPD, Asthma, Pneumonia, Diabetes, ESRD, Schizophrenia, Bi-Polar, Dizziness, History of Falls And * Medical or Surgical Unit patients * Age \> 18 years * Being discharged to home (with or without Home Health services) * English and/or Spanish speaking * Will have access to a telephone post-discharge * Ability to give consent * Patient admitted to hospital through the emergency department, as a direct admission or as a transfer, or as an elective surgery patient

Exclusion criteria

* \- Patients with observation status * Caremore Health Plan patients (Caremore has a separate post-discharge program) * Patients discharged and followed up by the PIH Coumadin Clinic * Patients discharged to Residential MD House Calls program * Patients discharged to Skilled Nursing Facility * Anyone with planned readmissions * Obstetrics patients * Hospice patients * Oncology patients * Anyone who does not meet provisions of protocol * Anyone unwilling or unable to give consent for study procedures and data access

Design outcomes

Primary

MeasureTime frameDescription
Proportion Patients with Hospital Reutilization30 days post hospital dischargeproportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026